GB0616450D0 - Treatment of pain - Google Patents
Treatment of painInfo
- Publication number
- GB0616450D0 GB0616450D0 GBGB0616450.3A GB0616450A GB0616450D0 GB 0616450 D0 GB0616450 D0 GB 0616450D0 GB 0616450 A GB0616450 A GB 0616450A GB 0616450 D0 GB0616450 D0 GB 0616450D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pain
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0616450A GB2441011A (en) | 2006-08-18 | 2006-08-18 | Pharmaceutical composition for the treatment of neuropathic pain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0616450A GB2441011A (en) | 2006-08-18 | 2006-08-18 | Pharmaceutical composition for the treatment of neuropathic pain |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0616450D0 true GB0616450D0 (en) | 2006-09-27 |
GB2441011A GB2441011A (en) | 2008-02-20 |
Family
ID=37081216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0616450A Withdrawn GB2441011A (en) | 2006-08-18 | 2006-08-18 | Pharmaceutical composition for the treatment of neuropathic pain |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2441011A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0517838D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Transdermal active principle delivery means |
WO2009103932A1 (en) * | 2008-02-19 | 2009-08-27 | Henderson Morley Plc | Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US7534768B2 (en) * | 2000-12-13 | 2009-05-19 | Henderson Morely Research And Development Ltd. | Treatment of DNA viral infections |
AU2003247496A1 (en) * | 2002-06-06 | 2003-12-22 | Matthew Davis | Cardiac glycosides for treating muscle pain and spasm |
JP2006514109A (en) * | 2002-12-18 | 2006-04-27 | アルゴルクス ファーマスーティカルズ,インク | Capsaicinoid administration |
GB0517838D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Transdermal active principle delivery means |
GB0517840D0 (en) * | 2005-09-02 | 2005-10-12 | Henderson Morley Plc | Topical anti viral formulations |
-
2006
- 2006-08-18 GB GB0616450A patent/GB2441011A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2441011A (en) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0610867D0 (en) | Treatment of pain | |
IL193748A0 (en) | Treatment of pain | |
IL248204A0 (en) | Combination treatment of cd38-expressing tumors | |
GB0602178D0 (en) | Therapeutic treatment | |
HK1207578A1 (en) | Treatment of synucleinopathies | |
IL198663A0 (en) | Tissue treatment methods | |
IL197315A0 (en) | Treatment of cancer | |
EP2049139A4 (en) | Treatment of ras-expressing tumors | |
GB0608655D0 (en) | Therapeutic Treatment | |
HK1255227A1 (en) | Pain treatment | |
ZA200806808B (en) | Treatment of stressed patients | |
EP1968591A4 (en) | Treatment of synucleinopathies | |
IL213703A (en) | Compounds for the treatment of pain and other diseases | |
GB0610909D0 (en) | Therapeutic treatment | |
ZA201000225B (en) | Treatment of depression | |
GB0610868D0 (en) | Treatment of pain | |
IL202639A0 (en) | Treatment of neuropathic pain | |
IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
GB0723100D0 (en) | Treatment of HFnEF | |
EP2124950A4 (en) | Treatment of pain with naloxone | |
EP2164494A4 (en) | Methods of treatment | |
GB0618060D0 (en) | Treatment of polyamides | |
GB0616450D0 (en) | Treatment of pain | |
GB0623740D0 (en) | Treatment of disease | |
GB0611417D0 (en) | Treatment of cndaria intoxication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |